Real-Time Continuous Glucose Monitoring in Adolescents and Young Adults With Type 2 Diabetes Can Improve Quality of Life
Authors' conclusion
Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes.
Study context
- Population
- And young adults (AYAs) aged 13–21 years with T2D for ≥6 months and HbA1c >7%, on any FDA-approved treatment; median age 19.1 years, 78% female, 100% people of color, 67% publicly insured; baseline HbA1c 11.9% (SD ±2.8%), 67% on insulin7 completed
- Participants
- 9 participants
- Outcome
- Feasibility and acceptability of real-time CGM use (sensor usage, surveys, focus group qualitative data)
- Follow-up
- 12 weeks
Methodological detailssingle-group, blinded run-in period
- Single-group
- Blinded run-in period
Main finding
As reported in the abstract
Completed the study
7 participants
Further findings
Diabetes-related quality of life (mean PedsQL diabetes score) · before vs after continuous glucose monitoring (CGM) use
- Mean PedsQL diabetes score increased from 70 to 75 after using CGM (statistically significant improvement)
- P = 0.026
- 7 completers
Original publication
Real-Time Continuous Glucose Monitoring in Adolescents and Young Adults With Type 2 Diabetes Can Improve Quality of Life. J Diabetes Sci Technol. Published 23 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →